FDA Clears IMRIS’ VISIUS Surgical Theatre Imaging System

Minnetonka, Minn.-based IMRIS received clearance from the U.S. Food and Drug Administration for the next generation of its VISIUS Surgical Theatre, an intraoperative imaging system.

Advertisement

VISIUS Surgical Theatre is a transportable magnetic resonance and computed tomography imaging system. Surgeons can request the system be brought to the operating room if necessary during a procedure, eliminating the need to move the patient for imaging and reducing the risk of patient harm, according to IMRIS‘ website.

This latest generation that received FDA clearance integrates Munich, Bavaria-based Siemens’ latest MR scanners and will “deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition and improved ease of use and workflow during neurosurgical procedures using intraoperative MRI,” according to the news release.

More Articles on FDA Cleared Devices:

FDA Clears Given Imaging’s PillCam COLON for Incomplete Colonoscopies
Sofosbuvir Earns FDA Approval as Hepatitis C Treatment
FDA Approves Medtronic’s CoreValve Transcatheter Without Panel Review

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.